Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories medical Devices — Segment Operating Earnings ($M) ($M)
Postgres DB segment_values + Form 10-K/10-Q XBRL
Latest, FY2025
7,212
Period ended Dec 31, 2025
Change on a year earlier
+17.2%
6,153 in FY2024
History
9 years
Since FY2017
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Medical Devices — Segment Operating Earnings ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7,212 | +17.2% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 6,153 | +16.0% | Form 10-K (filed 2025-02-21) ↗ |
| FY2023 | Dec 31, 2023 | 5,306 | +19.6% | Form 10-K (filed 2024-02-16) ↗ |
| FY2022 | Dec 31, 2022 | 4,436 | -2.1% | Form 10-K (filed 2024-02-16) ↗ |
| FY2021 | Dec 31, 2021 | 4,533 | +49.2% | Form 10-K (filed 2024-02-16) ↗ |
| FY2020 | Dec 31, 2020 | 3,038 | -19.4% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 3,769 | +7.7% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 3,500 | +16.2% | Form 10-K (filed 2020-02-21) ↗ |
| FY2017 | Dec 31, 2017 | 3,011 | – | Form 10-K (filed 2020-02-21) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Medical Devices — Segment Operating Earnings ($M) ($M), annual FY2017–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-seg-opinc-md
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.